Indicating that the company is still interested in the mega Tajpur deep sea port in West Bengal, JSW Infrastructure Ltd said that it remain...

As per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.

Market is riding on the optimism and the real test would begin with the earnings season.

Benchmark NSE Nifty50 index was up 40 points at 10,207, while BSE Sensex was up 115 points at 32,548.

Nifty50 index was trading around 9,840, while Sensex was hovering near 31,550-level.

Most experts said regulatory hurdles are going to be the biggest overhang for the sector and, hence, investors should remain selective.

I think that the bar is being raised in that industry both in cleanliness as well as in supply chain and quality of supply and APIs.

Orchid Pharma has received Establishment Inspection Report (EIR) from the US health regulator on the successful inspection closure for its ...

Orchid Chemicals Ltd rallied as much as 8.07 per cent in trade on Friday, after the pharma major received approval from the USFDA.

Even globally, look at what is happening in Pfizer, AstraZeneca we are seeing the impact of that in India today also.

The company had earlier acquired assets, improved efficiencies and subsequently sold them at attractive valuations.

Ashit Suri, Fundamental Research Analyst, JV Capital Services in an interview with ET Now talks about his pick from the pharma stocks.

'Eventful' would perhaps be the most apt term to describe the year 2008 for the Indian pharmaceutical industry.

'Eventful' would perhaps be the most apt term to describe the year 2008 for the Indian pharmaceutical industry. It saw hefty excise duty cu...

Ranbaxy said the pact with Orchid involved multiple geographies and therapies for both finished dosage forms and active pharmaceutical ingr...

Orchid Chemicals’ shares plunged 12.5% or Rs 40 to Rs 279 on Thursday from Wednesday’s close of Rs 319 at BSE.

As a proxy fight for the control of drug maker Orchid intensifies in the stock market, a key weapon in founder K Raghavendra Rao’s arsenal ...